154 related articles for article (PubMed ID: 37717042)
21. A weighted bilinear neural collaborative filtering approach for drug repositioning.
Meng Y; Lu C; Jin M; Xu J; Zeng X; Yang J
Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35039838
[TBL] [Abstract][Full Text] [Related]
22. BETA: a comprehensive benchmark for computational drug-target prediction.
Zong N; Li N; Wen A; Ngo V; Yu Y; Huang M; Chowdhury S; Jiang C; Fu S; Weinshilboum R; Jiang G; Hunter L; Liu H
Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35649342
[TBL] [Abstract][Full Text] [Related]
23. Inferring new drug indications using the complementarity between clinical disease signatures and drug effects.
Jang D; Lee S; Lee J; Kim K; Lee D
J Biomed Inform; 2016 Feb; 59():248-57. PubMed ID: 26707452
[TBL] [Abstract][Full Text] [Related]
24. Biomedical data and computational models for drug repositioning: a comprehensive review.
Luo H; Li M; Yang M; Wu FX; Li Y; Wang J
Brief Bioinform; 2021 Mar; 22(2):1604-1619. PubMed ID: 32043521
[TBL] [Abstract][Full Text] [Related]
25. MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug-Target Binding Affinity Prediction.
Wang S; Song X; Zhang Y; Zhang K; Liu Y; Ren C; Pang S
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176031
[TBL] [Abstract][Full Text] [Related]
26. A heterogeneous network-based method with attentive meta-path extraction for predicting drug-target interactions.
Wang H; Huang F; Xiong Z; Zhang W
Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35641162
[TBL] [Abstract][Full Text] [Related]
27. Time-resolved evaluation of compound repositioning predictions on a text-mined knowledge network.
Mayers M; Li TS; Queralt-Rosinach N; Su AI
BMC Bioinformatics; 2019 Dec; 20(1):653. PubMed ID: 31829175
[TBL] [Abstract][Full Text] [Related]
28. Computational drug repositioning through heterogeneous network clustering.
Wu C; Gudivada RC; Aronow BJ; Jegga AG
BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S6. PubMed ID: 24564976
[TBL] [Abstract][Full Text] [Related]
29. DDPD 1.0: a manually curated and standardized database of digital properties of approved drugs for drug-likeness evaluation and drug development.
Li Q; Ma S; Zhang X; Zhai Z; Zhou L; Tao H; Wang Y; Pan J
Database (Oxford); 2022 Feb; 2022():. PubMed ID: 35139189
[TBL] [Abstract][Full Text] [Related]
30. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
Turanli B; Gulfidan G; Arga KY
OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
[TBL] [Abstract][Full Text] [Related]
31. Identifying Gene Signatures for Cancer Drug Repositioning Based on Sample Clustering.
Wang F; Ding Y; Lei X; Liao B; Wu FX
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(2):953-965. PubMed ID: 32845842
[TBL] [Abstract][Full Text] [Related]
32. Drug Repositioning: A Unique Approach to Refurbish Drug Discovery.
Kale MA; Shamkuwar PB; Mourya VK; Deshpande AB; Shelke PA
Curr Drug Discov Technol; 2022; 19(1):e140122192307. PubMed ID: 33726652
[TBL] [Abstract][Full Text] [Related]
33. Task-driven knowledge graph filtering improves prioritizing drugs for repurposing.
Ratajczak F; Joblin M; Ringsquandl M; Hildebrandt M
BMC Bioinformatics; 2022 Mar; 23(1):84. PubMed ID: 35246025
[TBL] [Abstract][Full Text] [Related]
34. Computational drug repositioning based on multi-similarities bilinear matrix factorization.
Yang M; Wu G; Zhao Q; Li Y; Wang J
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33147616
[TBL] [Abstract][Full Text] [Related]
35. DrugSig: A resource for computational drug repositioning utilizing gene expression signatures.
Wu H; Huang J; Zhong Y; Huang Q
PLoS One; 2017; 12(5):e0177743. PubMed ID: 28562632
[TBL] [Abstract][Full Text] [Related]
36. Combining biomedical knowledge graphs and text to improve predictions for drug-target interactions and drug-indications.
Alshahrani M; Almansour A; Alkhaldi A; Thafar MA; Uludag M; Essack M; Hoehndorf R
PeerJ; 2022; 10():e13061. PubMed ID: 35402106
[TBL] [Abstract][Full Text] [Related]
37. A computational approach to drug repurposing using graph neural networks.
Doshi S; Chepuri SP
Comput Biol Med; 2022 Nov; 150():105992. PubMed ID: 36228466
[TBL] [Abstract][Full Text] [Related]
38. Knowledge Graphs for Indication Expansion: An Explainable Target-Disease Prediction Method.
Gurbuz O; Alanis-Lobato G; Picart-Armada S; Sun M; Haslinger C; Lawless N; Fernandez-Albert F
Front Genet; 2022; 13():814093. PubMed ID: 35360842
[TBL] [Abstract][Full Text] [Related]
39. A Review of Drug Repositioning Based Chemical-induced Cell Line Expression Data.
Wang F; Lei X; Wu FX
Curr Med Chem; 2020; 27(32):5340-5350. PubMed ID: 30381060
[TBL] [Abstract][Full Text] [Related]
40. Predicting Drug-Disease Associations via Using Gaussian Interaction Profile and Kernel-Based Autoencoder.
Jiang HJ; Huang YA; You ZH
Biomed Res Int; 2019; 2019():2426958. PubMed ID: 31534955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
